Towards the development of better therapeutic agents for Mycobacterium Tuberculosis: Computational design and evaluation of pyrazinone derivatives as inhibitors of enoyl acyl carrier protein reductase

This contains all the supporting information (SI) related to the manuscript, including supplementary figures, tables, and associated data referenced in the main text. These materials provide additional context and validation for the results and analyses presented in the study.